What comes next for telehealth in the U.S.? Some Wall Street analysts recently underscored the possibility of significant uptake in the technology — with caveats. “The number of potential use cases for virtual medicine being explored is growing exponentially, but technical and regulatory challenges remain,” Jefferies analysts cautioned in a recent note to investors on key takeaways from the American Telemedicine Association’s mid-April conference in New Orleans.
- People on the Move
- Drug Benefits
- Datapoint, Medicare and Medicaid
- Abstract, Medicare and Medicaid
- Headlines in the News